Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
the actual benefit of CERVARIX remains substantial only the Marketing Authorisation indications recommended by the HCSP in the current vaccination schedule. |
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
Tj5wv5X2Rmww30pw
